ProCE Banner Activity

CME

Hepatitis C Update: A Growing Challenge With Evolving Management Solutions

In this updated interactive presentation targeted to primary care clinicians, hepatitis expert Terry D. Box, MD, reviews the changing epidemiology of hepatitis C infections, age- and risk-based HCV screening, follow-up after testing in the primary care and specialist settings, and counseling patients on the benefits of HCV screening and treatment.
Physicians : maximum of 0.75 AMA PRA Category 1 {Credit}

Released: January 17, 2018

Expiration: January 16, 2019

No longer available for credit.

Share

Faculty

Terry D. Box

Terry D. Box, MD

Associate Professor of Medicine
Department of Internal Medicine
Division for Gastroenterology, Hepatology, Nutrition
University of Utah School of Medicine
Salt Lake City, Utah

Brian L. Pearlman

Brian L. Pearlman, MD, FACP, FAASLD

Medical Director, Center for Hepatitis C
Wellstar Atlanta Medical Center
Atlanta, Georgia
Professor of Medicine
Medical College of Georgia
Augusta, Georgia
Associate Professor of Medicine
Emory School of Medicine
Atlanta, Georgia

Mary Speigle

Mary Speigle, NP

Nurse Practitioner
Shasta Community Health Center
Redding, California

Provided by

Jointly provided by Primary Care Network and Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead

Target Audience

This program is intended for internists, family physicians, nurse practitioners and physician assistants.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply current guidelines on age-cohort and risk-based HCV screening
  • Appropriately manage newly diagnosed and other untreated HCV patients, including staging and counseling them regarding the multiple health consequences of HCV infection
  • Accurately counsel patients regarding current HCV treatment options, including recommended timing of treatment and key characteristics of current regimens
  • Appropriately distinguish between HCV-infected patients who can be managed in primary care vs those requiring linkage to specialist care

Faculty Disclosure

Primary Author

Terry D. Box, MD

Associate Professor of Medicine
Department of Internal Medicine
Division for Gastroenterology, Hepatology, Nutrition
University of Utah School of Medicine
Salt Lake City, Utah

Terry D. Box, MD, has disclosed that he has served on advisory boards for AbbVie, Bayer, Gilead Sciences, and Intercept; has received funds for research support from Gilead Sciences and Merck; and has served on speaker bureaus for Gilead Sciences.

Brian L. Pearlman, MD, FACP, FAASLD

Medical Director, Center for Hepatitis C
Wellstar Atlanta Medical Center
Atlanta, Georgia
Professor of Medicine
Medical College of Georgia
Augusta, Georgia
Associate Professor of Medicine
Emory School of Medicine
Atlanta, Georgia

Brian Pearlman, MD, has disclosed that he has served on advisory boards for Merck; has received funds for research support from AbbVie, Gilead Sciences, and Merck; and has served on speaker bureaus for AbbVie, Gilead Sciences, and Merck.

Mary Speigle, NP

Nurse Practitioner
Shasta Community Health Center
Redding, California

Mary Speigle, NP, has no relevant financial relationships to disclose.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no relevant financial relationships to disclose.

Cindy Fisher,

CME Program Manager, PCN
Springfield, Missouri

Cindy Fisher has no relevant financial relationships to disclose.

Jill Hays, CHCP

PCN Content Reviewer
Executive Director
Primary Care Network
Springfield, Missouri

Jill Hays, CHCP, has no relevant financial relationships to disclose.

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

Edward King, MA, has no relevant financial relationships to disclose.

Brian Koffman, MDCM

PCN Content Reviewer
Medical Director, CLL Society Inc.
Partner, St Jude Heritage Medical Group
Diamond Bar, California
Clinical Professor (Retired)
Department of Family Medicine
Keck School of Medicine, USC Family Practice
Los Angeles, California

Consultant: Ironwood, Janssen Pharmaceuticals, Inc. Stockholder: AbbVie, AstraZeneca, Bristol-Myers Squibb, Gilead Sciences, Mei Pharma, Sunesis, Verastem

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no relevant financial relationships to disclose.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant financial relationships to disclose.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and Clinical Care Options. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Primary Care Network designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 17, 2018, through January 16, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve primary care clinicians’ competence in the diagnosis and management of uncomplicated chronic hepatitis C infection.